News
Hosted on MSN1mon
Windtree Therapeutics and Evofem Announce Agreement to Lower Manufacturing Costs for PHEXXI®â€œThe meaningful decrease in the per-box cost of PHEXXI that we expect to achieve with Windtree’s assistance should allow Evofem to take PHEXXI into new, price-sensitive global markets where ...
"The meaningful decrease in the per-box cost of PHEXXI that we expect to achieve with Windtree's assistance should allow Evofem to take PHEXXI into new, price-sensitive global markets where there ...
“The meaningful decrease in the per-box cost of PHEXXI that we expect to achieve with Windtree’s assistance should allow Evofem to take PHEXXI into new, price-sensitive global markets where ...
PHEXXI annual revenues have grown to more than $19 million with more than 96,000 boxes of 12 pre-filled applicators sold in full year 2024. Windtree has manufacturing contacts that we believe are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results